Tempus Pixel设备升级版获特别510许可 Tempus AI(TEM.US)大涨超13%

Core Viewpoint - Tempus AI's stock surged over 13%, nearing its previous high, following the announcement of FDA approval for its updated Tempus Pixel device, marking a significant regulatory milestone in the cardiac imaging field [1] Company Summary - Tempus AI's updated Tempus Pixel device received special 510(k) clearance from the FDA, allowing it to be commercially used in the United States [1] - The stock price reached $88.81 after the announcement, indicating strong market reaction and investor confidence [1]